Cytochrome P450-derived arachidonic acid metabolism in the rat kidney: Characterization of selective inhibitors

Journal of Pharmacology and Experimental Therapeutics

Volumn 284, Issue 3, 1998, Pages 966-973

  Wang, Mong Heng ^a   Brand Schieber, Elimor ^a   Zand, Barbara A ^a   Nguyen, Xuandai ^a   Falck, John R ^b   Balu, Narayanan ^b   Schwartzman, Michal Laniado ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

12,12 DIBROMODODEC 11 ENOIC ACID; 17 OCTADECYNOIC ACID; 20 HYDROXYICOSATRIENOIC ACID; 6 (2 PROPARGYLOXYPHENYL)HEXANOIC ACID; ALKENE DERIVATIVE; ARACHIDONIC ACID; ARACHIDONIC ACID DERIVATIVE; CYTOCHROME P450 INHIBITOR; CYTOCHROME P450 ISOENZYME; EPOXYICOSATRIENOIC ACID; N METHANESULFONYL 6 (2 PROPARGYLOXYPHENYL)HEXANAMIDE; N METHYLSULFONYL 12,12 DIBROMODODEC 11 ENAMIDE; N METHYLSULFONYL 15,15 DIBROMOPENTADEC 14 ENAMIDE; OXYGENASE; RECOMBINANT PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME ACTIVITY; EPOXIDATION; HYDROXYLATION; KIDNEY MICROSOME; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ARACHIDONIC ACID; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INHIBITORS; EPOXY COMPOUNDS; HYDROXYLATION; KIDNEY; MALE; MICROSOMES; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS;

EID: 0031887331     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Alkayed NJ, Birks EK, Hudetz AG, Roman RJ, Henderson L and Harder DR (1996) Inhibition of brain P-450 arachidonic acid epoxygenase decreases baseline cerebral blood flow. Am J Physiol 271:H1541-H1546.
2. Alonso-galicia M, Drummond HA, Kishta Reddy K, Falck JR and Roman RJ (1997) Inhibition of 20-HETE production contributes to the vascular responses to nitric oxide. Hypertension 29:320-325.
3. Alterman MA, Chaurasia CS, Lu P, Hardwick JP and Hanzlik RP (1995) Fatty acid discrimination and ω-hydroxylation by cytochrome P450 4A1 and cytochrome P4504A1/NADPH-P450 reductase fusion protein. Arch Biochem Biophys 320: 289-296.
4. + channels by cytochrome P450 inhibitors. J Biol Chem 267:11789-11793.
5. Bambal RB and Hanzlik RP (1996) Active site structure and substrate specificity of cytochrome P450 4A1: Steric control of ligand approach perpendicular to heme plane. Biochem Biophys Res Commun 219:445-449.
6. Brand-Schieber E, Takizawa H, Falck JR, Laniado Schwartzman M and Nasjletti A (1996) Increased dietary salt attenuates a renal vasoconstrictor mechanism mediated by 20-HETE (Abstract). Hypertension 28:539.
7. Capdevila J, Gil L, Orellana M, Marnett LJ, Mason JI, Yadagiri P and Falck JR (1988) Inhibitors of cytochrome P450 dependent arachidonic acid metabolism. Arch Biochem Biophys 261:257-263.
8. Capdevila JH, Shouzou W, Yan J, Karara A, Jacobson HR, Falck JR, Guengerich FP and DuBois RN (1992) Cytochrome P450 arachidonic acid epoxygenase: Regulatory control of the renal epoxygenase by dietary salt loading. J Biol Chem 267: 21720-21726.
9. Carroll MA, Pilar Gracia M, Falck JR and McGiff JC (1992) Cyclooxygenase dependency of the renovascular actions of cytochrome P450-derived arachidonate metabolites. J Pharmacol Exp Ther 260:104-109.
10. Dees JH, Masters BBS, Muller-Eberhard V and Johnson EF (1982) Effects of 2,3,7,8-tetchlorodibenzo-p-dioxin and phenobarbital on the occurrence and distribution of four cytochrome P450 isozymes in rabbit kidney, lung and liver. Can Res 42: 1423-1432.
11. Escalante B, Erlij D, Falck JR and McGiff JC (1994) Cytochrome P450 arachidonate metabolites affect ion fluxes in rabbit medullary thick ascending limb. Am J Physiol 266:C1775-C1782.
12. Falck JR, Belosludtsev Y, Kishta Reddy K, Malla Reddy K, Fiona Shortt M and Chauhan K (1997) Eicosanoid biosynthesis: Differential inhibition of cytochrome P450 epoxygenase and ω-hydroxylase. Bioorg Medicinal Chem Lett 7:3053-3056.
13. Fulton D, Mahboubi K, McGiff JC and Quilley J (1995) Cytochrome P450-dependent effects of bradykinin in the rat heart. Br J Pharmacol 114:99-102.
14. Gebremedhin D, Ma Y-H, Imig JD, Harder DR and Roman RJ (1993) Role of cytochrome P450 in elevating renal vascular tone in spontaneously hypertensive rats. J Vase Res 30:53-60.
15. Gonzalez FJ (1988) The molecular biology of cytochrome P450. Pharmacol Rev 40: 275-288.
16. Hardwick JP (1991) CYP 4A subfamily: Functional analysis by immunocytochemistry and in situ hybridization. Meth Enzymol 206:273-283.
17. + exchange and are mitogenic in cultured rat glomerular mesangial cells. Cell Physiol 144:429-437.
18. Helvig C, Alayrac C, Mioskowski C, Koop D, Poullain D, Drust F and Salaun J-P (1997) Suicide inactivation of cytochrome P450 by midchain and terminal acetylenes. A mechanistic study of inactivation of a plant lauric acid ω-hydroxylase. J Biol Chem 272:414-421.
19. Hirt HL, Capdevila J, Falck JR, Breyer MD and Jacobson HR (1989) Cytochrome P450 metabolites of arachidonic acid are potent inhibitors of vasopressin action on rabbit cortical collecting duct. J Clin Invest 84:1805-1812.
20. Imaoka S, Tanaka S and Funae Y (1989) ω-and (ω-1)-Hydroxylation of lauric acid and arachidonic acid by rat renal cytochrome P-450. Biochem Int 18:731-740.
21. Imig JD, Falck JR, Gebremedhin D, Harder DR and Roman RJ (1993) Elevated renovascular tone in young spontaneously hypertensive rats: Role of cytochrome P450. Hypertension 22:357-364.
22. Imig JD, Zou A-P, Stec DE, Harder DR, Falck JR and Roman RJ (1996) Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles. Am J Physiol 270:R217-R227.
23. Katoh T, Takahashi K, Capdevila J, Karara A, Falck JR, Jacobson HR and Badr KF (1991) Glomerular stereospecific synthesis and hemodynamic actions of 8,9-epoxyeicosatrienoic acid in rat kidney. Am J Physiol 261:F578-F586.
24. Kauser K, Clark JE, Masters BS, Ortiz de Montellano PR, Ma Y-H, Harder DR and Roman RJ (1991) Inhibitors of cytochrome P450 attenuate the myogenic response of dog renal arcuate arteries. Circ Res 68:1154-1163.
25. Kimura S, Hanioka N, Matsunaga E and Gonzalez FJ (1989a) The rat clofibrate-inducible CYP4A gene subfamily. I. Complete intron and exon sequence of the CYP4A1 and CYP4A2 genes, unique exon organization, and identification of a conserved 19-bp upstream element. DNA 8:503-516.
26. Kimura S, Hardwick JP, Kozak CA and Gonzalez FJ (1989b) The rat clofibrate-inducible CYP4A gene subfamily. II. cDNA sequence of IVA3, mapping of the Cyp4a locus to mouse chromosome 4, and coordinate and tissue-specific regulation of the CYP4A genes. DNA 8:517-525.
27. Laethem RM, Balazy M, Falck JR, Laethem CL and Koop DR (1993) Formation of 19(S)-, 19(R)-, and 18(R)-hydroxyeicosatetraenoic acids by alcohol-inducible cytochrome 2E1. J Biol Chem 268:12912-12918.
28. Laethem RM, Halpert JR and Koop DR (1994) Epoxidation of arachidonic acid as an active-site probe of cytochrome p-450 2B isoforms. Biochim Biophys Acta 1206: 42-48.
29. Laethem RM and Koop DR (1992) Identification of rabbit cytochrome P450 2C1 and 2C2 as arachidonic acid epoxygenase. Mol. Pharmacol 42:958-963.
30. Laniado Schwartzman M, Da Silva J-L, Lin F, Nishimura M and Abraham NG (1996) Cytochrome P450 4A expression and arachidonic acid ω-hydroxylation in the kidney of the spontaneously hypertensive rat. Nephron 73:652-663.
31. Ma Y-H, Gebremedhin D, Schwartzman ML, Falck JR, Clark JE, Masters BSS, Harder DR and Roman RJ (1993) 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries. Circ Res 72:126-136.
32. Makita K, Takahashi K, Karara A, Jacobson HR, Falck JR and Capdevila JH (1994) Experimental and/or genetically controlled alterations of the renal microsomal cytochrome P450 epoxygenase induced hypertension in rats fed a high salt diet. J Clin Invest 94:2414-2420.
33. Mancy A, Dijols S, Poli S, Guengerich FP and Mansuy D (1996) Interaction of sulfaphenazole derivatives with human liver cytochrome P450 2C: Molecular origin of the specific inhibitory effects of sulfaphenazole on CYP 2C9 and consequences for substrate binding site topology of CYP 2C9. Biochemistry 35:16205-16212.
34. Muerhoff AS, Williams DE, Reich NO, CaJacob CA, Ortiz de Montellano PR and Masters BSS (1989) Prostaglandin and fatty acid ω-and (ω-1)-oxidation in rabbit lung. Acetylenic fatty acid mechanism-based inactivators as specific inhibitors. J Biol Chem 264:749-756.
35. Nguyen XN, Wang M-H and Schwartzman ML (1997) Fatty acid metabolism by cytochrome P450 4A3 expressed in baculovirus-insect cell system. FASEB J 11: A805.
36. Oliw EH, Guengerich FP and Oates JA (1982) Oxygenation of arachidonic acid by hepatic monooxygenase: Isolation and metabolism of four expoxide intermediates. J Biol Chem 257:3771-3781.
37. Omata K, Abraham NG and Laniado-Schwartzman M (1992) Arachidonic acid ω/ω-1 hydroxylase along the nephron of the spontaneously hypertensive rat. Am J Physiol 262:F592-599.
38. Omura T and Sato R (1964) The carbon monoxide binding pigment of liver microsomes. J Biol Chem 239:2370-2379.
39. Ortiz de Montellano PR and Reich NO (1984) Specific inactivation of hepatic fatty acid hydroxylases by acetylenic fatty acids. J Biol Chem 259:4136-4141.
40. Rifkind AB, Lee C, Chang TKH and Waxman DJ (1995) Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1 and 1A2: Regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes. Arch Biochem Biophys 320:380-389.
41. Sacerdoti D, Escalante B, Abraham NG, McGiff JC, Levere RD and Schwartzman ML (1989) Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats. Science (Wash DC) 243:388-390.
42. Sakairi Y, Jacobson HR, Noland TD, Capdevila JH, Falck JR and Breyer MD (1995) 5,6-EET inhibits ion transport in collecting ducts by stimulating endogenous prostaglandin synthesis. Am J Physiol 268:F931-F939.
43. Stromstedt M, Hatashi SI, Zaphirophoulus PG and Gustafsson JA (1990) Cloning and characterization of a novel member of the cytochrome P450 subfamily IVA in rat prostate. DNA 9:567-577.
44. Takahashi KJ, Capdevila A, Karara JR, Falck JR, Jacobson HR and Badr KF (1990) Cytochrome P450 arachidonate metabolites in rat kidney: Characterization and hemodynamic responses. Am J Physiol 258:F781-F789.
45. Testa B and Jenner P (1981) Inhibitors of cytochrome P450s and their mechanism of action. Drug Metab Rev 12:1-117.
46. Wang M-H, Stec DE, Balazy M, Mastyugin V, Yang CS, Roman RJ and Laniado Schwartzman M (1996) Cloning, sequencing and cDNA-directed expression of the rat renal CYP4A2: Arachidonic acid ω-hydroxylation and 11,12-epoxidation by CYP4A2 protein. Arch Biochem Biophys 336:240-250.
47. + channel in the thick ascending limb of the rat kidney. J Gen Physiol 106:727-743.
48. Zou A-P, Imig JD, Kaldunski M, Ortiz de Montellano PR, Sui Z and Roman RJ (1994a) Inhibition of renal vascular 20-HETE production impairs autoregulation of renal blood flow. Am J Physiol 266:F275-F282.
49. Zou A-P, Drummond HA and Roman HJ (1996a) Role of 20-HETE in elevating loop chloride reabsorption in Dahl SS/Jr rats. Hyperten 27:631-635.
50. Zou A-P, Fleming JT, Falck JR, Jacobs ER, Gebremedhin D, Harder DR and Roman RJ (1996b) Stereospecific effects of epoxyeicosatrienoic acids on renal vascular tone and K-channel activity. Am J Physiol 270:F822-F832.
51. + channel in renal arterioles. Am J Physiol 270:R228-R237.
52. Zou A-P, Imig JD, Ortiz de Montellano PR, Sui Z, Falck JR and Roman RJ (1994b) Effect of P450 ω-hydroxylase metabolites of arachidonic acid on tubuloglomerular feedback. Am J Physiol (Renal Fluid Electrolyte Physiol) 266:F934-F941.
53. Zou A-P, Ma Y-H, Sui Z-H, Ortiz de Montellano PR, Clark JE, Masters BS and Roman RJ (1994c) Effect of 17-octadecynoic acid, a suicide-substrate inhibitor of cytochrome P450 fatty acid ω-hydroxylase, on renal function. J Pharmacol Exp Ther 268:474-481.